These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12715963)

  • 1. Aetiology of drug-induced severe bullous reactions.
    Sen M; George R; Shankar V; Thomas M; Thomas K
    Natl Med J India; 2003; 16(1):50-1. PubMed ID: 12715963
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis in lenalidomide-treated patients.
    Castaneda CP; Brandenburg NA; Bwire R; Burton GH; Zeldis JB
    J Clin Oncol; 2009 Jan; 27(1):156-7. PubMed ID: 19047275
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis.
    Wagner FF; Flegel WA
    N Engl J Med; 1996 Apr; 334(14):922; author reply 923. PubMed ID: 8596590
    [No Abstract]   [Full Text] [Related]  

  • 8. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
    Kelly JP; Kaufman DW; Dunant A; Mockenhaupt M; Roujeau JC
    J Am Acad Dermatol; 2011 Jun; 64(6):1193-4. PubMed ID: 21571188
    [No Abstract]   [Full Text] [Related]  

  • 9. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
    Wanat KA; Anadkat MJ; Klekotka PA
    J Am Acad Dermatol; 2009 Apr; 60(4):589-94. PubMed ID: 19217690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug eruptions caused by sulphonamides].
    Kuokkanen K; Palatsi R
    Duodecim; 1971; 87(5):362-6. PubMed ID: 4252615
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
    Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC
    Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMPACT syndrome.
    Mockenhaupt M; Roujeau JC
    J Dtsch Dermatol Ges; 2005 Jul; 3(7):569-70; author reply 570. PubMed ID: 15967019
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of cutaneous risk in pharmacovigilance: metabolic predisposition to Stevens-Johnson syndromes and toxic epidermal necrolysis].
    Wolkenstein P
    Therapie; 1996; 51(5):500-1. PubMed ID: 9138383
    [No Abstract]   [Full Text] [Related]  

  • 14. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythema multiforme exudativum, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's syndrome) and their interrelationship].
    Kalamkarian AA; Samsonov VA
    Vestn Dermatol Venerol; 1980 Mar; (3):36-42. PubMed ID: 6990649
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection.
    Porteous DM; Berger TG
    Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245
    [No Abstract]   [Full Text] [Related]  

  • 17. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cotrimoxazole induced dermatitis and curative treatment of AIDS pneumocystosis].
    Caumes E
    Rev Mal Respir; 1996; 13(2):101-6. PubMed ID: 8711227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fever, rash, and peeling skin.
    Cairns B; Rich M
    J Fam Pract; 2011 Jan; 60(1):9-12. PubMed ID: 21209972
    [No Abstract]   [Full Text] [Related]  

  • 20. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ukponmwan CU; Njinaka I; Ehimiyen ET
    Trop Doct; 2010 Jul; 40(3):167-8. PubMed ID: 20555046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.